Related Experiment Video
Updated: Nov 3, 2025

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
3.2K
In Silico Mathematical Modelling for Glioblastoma: A Critical Review and a Patient-Specific Case.
Jacopo Falco1, Abramo Agosti2, Ignazio G Vetrano1
1Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Journal of Clinical Medicine
|June 2, 2021
Summary
Mathematical models offer new insights into glioblastoma (GBM) tumor evolution. This research reviews these models, highlighting their potential to improve glioblastoma treatment and patient outcomes.
Area of Science:
- Neuro-oncology
- Biomathematics
- Computational Biology
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with a poor prognosis despite current treatments.
- Understanding GBM evolution at a patient-specific level is crucial for developing tailored therapies.
- A multidisciplinary approach integrating mathematical, clinical, and radiological data is promising.
Purpose of the Study:
- To critically review mathematical models used in neuro-oncology for glioblastoma.
- To classify existing models and identify significant advancements.
- To explore the clinical implications and potential benefits of mathematical modeling in GBM patient care.
Main Methods:
- Comprehensive literature search and review of English-language articles on mathematical modeling in glioblastoma.
- Classification and analysis of different mathematical models and their contributions.
- Application of a novel mechanical model to a specific glioblastoma patient case.
Main Results:
- Identified and classified various mathematical models for glioblastoma.
- Demonstrated the potential of these models to describe tumor complexity and predict evolution.
- Presented a case study showcasing the application of an innovative mechanical model.
Conclusions:
- Mathematical models hold significant potential to benefit clinicians and improve glioblastoma treatment strategies.
- These models can aid in enhancing tumor control and improving patient prognosis.
- Further prospective comparative trials are needed to validate the clinical impact of mathematical neuro-oncology.

